Diseases of affluence (diseases of the XXI c., Western diseases) by definition should have higher prevalence and/or mortality rates in richer and more developed countries than in poorer, underdeveloped states. Therefore, it has been indicated that it is the civilizational progress (directly or indirectly via changes in lifestyle, diet, physical activity, stress, etc.) that stimulates epidemic outbreaks of some illnesses (cancer, diseases of respiratory and cardiovascular systems, diabetes, mental disorders). On the other hand substantial financial resources, highly qualified medical personnel, and cutting-edge technology of richer states, should allow for effective preventions, diagnostics, and treatment of these diseases.
Introduction
In the modern world new and unexpected medical dangers constantly arise. It may mean new diseases, naturally mutated or bioengineered, but more and more often also changes in epidemiological patterns of existing disorders. The diseases of affluence, also known as the diseases of XXI c. or Western diseases, in last decades have become an alarming phenomena.
Well known illnesses, like cardiovascular diseases, respiratory system diseases, cancer, diabetes, or mental disorders (including addictions) have re-appeared as a modern diseases and severe problem addressed in many WHO reports (WHO Report: ATLAS 2010…: pp.7-22; WHO Report: Global Report… 2016: pp.90-91; WHO Report: Global status…2011: pp.1-160). Statistics shows that almost half of deaths in most developed countries are caused by the cardiovascular problems, which is considered to be the flag example of the diseases of affluence. However, there is no unified definition or established list of the infamous XXI c.
diseases. Nevertheless, it is generally believed that regions with higher economic indicators are more at risk, than the poorer ones. Though, there is no irrefutable evidence or methodology to state that any disease is influenced by regional socio-economic development.
These illnesses are considered to be, direct or indirect, cost and by-product of social, cultural, technological, and economic progress in highly developed societies. (Kotarski 2013: 117-125; Link 2007: 75-76; Aue 2009: 175) . Proving or disproving some of common notions may turn out to be very beneficial for the assessment and the development of regional, international, and global policies regarding the diseases of XXI c. For the purpose of this analysis the hypothesis of diseases of affluence can be statute as: the more affluent (wealthy, developed etc.) the object (country, region, social group, household, person etc.) , the more intense the prevalence (frequency of cases, severity of symptoms, mortality rate etc.) of the disease.
The European Union as a whole, as well as all its member states and their regions, may be considered as "highly developed" region in an economic sense. Does it, however, mean that EU can be perceived as homogeneous in the sense of diseases of affluence epidemiology? Does economic diversity in EU (relatively small compared to worldwide inequalities) constitute a significant factor for the spatial distribution of diseases of affluence? To evaluate possible dispersion in the epidemiology of some of potential Western Diseases and their correlation with regional development, some tools of spatial statistics have been incorporated. Namely, uni-and bivariate local and global Moran's I statistics.
There are 3 specific aims of this paper: (1) verifying clustering of similar regions with high or low prevalence of each disease, (2) assessing the regional relation between economic development and the prevalence of each disease, (3) verifying if this regional relation (proving or disproving the existence of diseases of affluence) is constant both over time and space. Therefore, these research may provide some answers to the questions concerning existence and epidemiology of potential diseases of affluence as well as it may allow for the recognition of the spatial patterns of prevalence and mortality rates for these illnesses.
Data
Data used in this statistical analysis represent death rates of the prevalence of each disease.
Using mortality by the cause of death, as a measure of epidemiology is debatable, however in a way it does represent the prevalence. The death rates are in this case a result of combined effect of: the real prevalence or epidemiology (the number of people ill), the efficiency of diagnostics (the number of diagnosed cases of the illness), and health care efficiency (people living with the disease and possibly dying from different causes). It is difficult, if not impossible, to state which factor is decisive, and weather it is constant in time and space.
However, there is very little data on prevalence, or even diagnosed prevalence available. It should be mentioned, that in the case of spatial statistics the dataset needs to be complete for all regions, to implement the spatial weight matrix. Therefore, the death rates analysis should be treated as a compromise between theory, speaking of prevalence or epidemiology, and the availability of data. In this analysis 5 potential diseases of affluence are considered: diabetes, diseases of the respiratory system, neoplasms (cancer), diseases of the circulatory system (cardiovascular diseases), and finally mental and behavioural disorders. This may indicate that mental disorders are diseases of affluence (see Fig.1 ). There is no clear or uniform patterning of these five diseases. Concluding, decile mapping alone does not give an answer weather any of these illnesses can be considered as a disease of affluence or diseases of poverty, or in general if there is any dependence between prevalence and socioeconomic development. Therefore, a further and more detailed analysis needs to be carried out. 2. Prevalence of potential diseases of affluence is not limited by regional borders.
3. Regional correlation of: a) high GDP per capita with high mortality regions b) low GDP per capita with low mortality regions will confirm the affluence hypothesis, while mixed clusters (low-high) will prove otherwise.
Assumptions 1 and 2 reflect the common notion that regional borders do not limit any nonphysical phenomena, especially in the EU with common market and no-border policy.
Assumption 3 allows for identification of diseases of affluence, and by association -diseases of poverty.
The classic or univariate Moran's statistic (Moran, 1950; Cliff and Ord, 1981; Suchecki, 2010) is the most popular test of spatial association. The local Moran's shows whether the -th location is surrounded by locations with similar or opposite values. The local Moran's statistic or Local Indicators of Spatial Association (LISA) takes the following form:
The global Moran's is a mean of local Moran's statistics and measures general regional similarity for all regions:
where ̅ means mean of a given process and elements of W matrix, which in this paper is based on queen contiguity spatial weight matrix, 1 st order (Anselin, 1988 
where ̅ is a mean of the 2 nd variable. The global equivalent Moran's I is:
All spatial analyses are based on queen contiguity spatial weight matrix, 1 st order (Anselin, 1988) .
Results and discussion
Analysing epidemic spatial clustering over NUTS 2 regions and time indicates unique patterning for each disease. Only statistically significant clustering is taken in to consideration (see fig.2 ). Existence of large and positively correlated clusters, exceeding not only province but also state borders, supports the assumption concerning spilling over of Western diseases' prevalence and mortality. This also may be an indicator of dependence between regional economic development and epidemiology. However, this relationship needs further research. Europe, especially Balkans, there are strong indicators that diabetes mortality rates' distribution has markings of Western diseases. Nevertheless the pattern changes over time of analysis, which means that mortality increases faster than economic development in these regions.
Diseases of the respiratory system clustering is very similar to diabetes -in the Central and Eastern Europe we observe large low mortality -low GDP and high mortality -low GDP groups, while in the Western Europe we recognise few high mortality -high GDP and low mortality -high GDP clusters. However, over the time number of high-high and low-low 
Summary
While analysing, interpreting, and concluding some mixed and unexpected results rose for 4 out of 5 diseases in questions (excluding mental disorders). This may be attributed partly to two not strictly statistical factors. Firstly, it needs to be remember that the prevalence was measured by the death rates, i.e. mortality, it the total population. This could not be avoided due to lacking data. However, it fact we do not know if the prevalence sesnu stricto, that is the number of ill people or their fraction in the population, is spatially correlated to the level of economic development. Moreover, we do not know if the mortality among ill people is constant (over time and space) or if it maybe is spatially correlated to GDP level as well. It may be reasoned that the more developed region (due to better health care), the lower mortality (among the sick or in the population). If so, it can be observed by the mixed relations (high-low, low-high) and in fact be perceived as a symptom of diseases of poverty, where more people die in poorer and underdeveloped (socioeconomically and also medically)
regions. Interloping of small low-low/high-high clusters with mixed groups and transforming one into the other over time proves that the "disease of affluence" is not a fixed distinction forming a constant list of illnesses with constant and fixed distributions over time and space.
Secondly, the analysed region of EU is fairly homogeneous in the sense of mortality and economic development, compared to the dispersion in the rest of the world. Therefore, the potential relations may be weaker thus more difficult to find and confirm statistically.
Diabetes, respiratory system diseases, and cancer can be perceived as diseases of affluence in some regions, mainly in poorer provinces of Central and Eastern Europe. There, lower mortality is the reflection of lower prevalence senus stricto. However, in some neighbouring regions the relation is inversed -low economic development correlates with high mortality. In these regions high death rates might be a result of higher prevalence and/or worse health care.
Either way, more attention should be paid to these regions in creating health care policies, as they are in danger of socioeconomic inequality in access to medical aid.
Cardiovascular diseases are perceived as a flag example of diseases of affluence and yet the outcomes of this research indicate the exact opposite. In the sense of mortality caused by hart problems, it is a strong example of a disease of poverty. Clearly, more people die in poorer regions than in more developed ones. Again, we still cannot conclude if (1) the prevalence (number or fraction of ill in population) is positively or negatively correlated with GDP, (2) health care in richer states offers longer life with a diseases, but the fact is that people are more likely to die of cardiovascular diseases in Central and Eastern Europe than in the Western states.
Mental disorders measured by death rate surprisingly is strongly and positively correlated with economic development. While these illnesses are unique on their own and their mortality (suicides, addiction related deaths, etc.) is not as intuitive as with cancer or cardiovascular diseases, the spatial statistical approach clearly shows that they are a good example of Western diseases. Moreover since the relation is fairly clear in a homogenous region of EU, it can be concluded that in fact this mortality is very sensitive to small changes in economic development.
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